208 related articles for article (PubMed ID: 22570471)
21. Extension of human cell lifespan by nicotinamide phosphoribosyltransferase.
van der Veer E; Ho C; O'Neil C; Barbosa N; Scott R; Cregan SP; Pickering JG
J Biol Chem; 2007 Apr; 282(15):10841-5. PubMed ID: 17307730
[TBL] [Abstract][Full Text] [Related]
22. Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration.
Zhao G; Green CF; Hui YH; Prieto L; Shepard R; Dong S; Wang T; Tan B; Gong X; Kays L; Johnson RL; Wu W; Bhattachar S; Del Prado M; Gillig JR; Fernandez MC; Roth KD; Buchanan S; Kuo MS; Geeganage S; Burkholder TP
Mol Cancer Ther; 2017 Dec; 16(12):2677-2688. PubMed ID: 29054982
[TBL] [Abstract][Full Text] [Related]
23. Preclinical models of nicotinamide phosphoribosyltransferase inhibitor-mediated hematotoxicity and mitigation by co-treatment with nicotinic acid.
Tarrant JM; Dhawan P; Singh J; Zabka TS; Clarke E; DosSantos G; Dragovich PS; Sampath D; Lin T; McCray B; La N; Nguyen T; Kauss A; Dambach D; Misner DL; Diaz D; Uppal H
Toxicol Mech Methods; 2015 Mar; 25(3):201-11. PubMed ID: 25894564
[TBL] [Abstract][Full Text] [Related]
24. FK866, a highly specific noncompetitive inhibitor of nicotinamide phosphoribosyltransferase, represents a novel mechanism for induction of tumor cell apoptosis.
Hasmann M; Schemainda I
Cancer Res; 2003 Nov; 63(21):7436-42. PubMed ID: 14612543
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma.
Wang XY; Wang JZ; Gao L; Zhang FY; Wang Q; Liu KJ; Xiang B
Toxicol Appl Pharmacol; 2017 Sep; 331():54-61. PubMed ID: 28501332
[TBL] [Abstract][Full Text] [Related]
26. Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion.
Tateishi K; Wakimoto H; Iafrate AJ; Tanaka S; Loebel F; Lelic N; Wiederschain D; Bedel O; Deng G; Zhang B; He T; Shi X; Gerszten RE; Zhang Y; Yeh JJ; Curry WT; Zhao D; Sundaram S; Nigim F; Koerner MVA; Ho Q; Fisher DE; Roider EM; Kemeny LV; Samuels Y; Flaherty KT; Batchelor TT; Chi AS; Cahill DP
Cancer Cell; 2015 Dec; 28(6):773-784. PubMed ID: 26678339
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of nicotinamide phosphoribosyltransferase modifies LPS-induced inflammatory responses of human monocytes.
Schilling E; Wehrhahn J; Klein C; Raulien N; Ceglarek U; Hauschildt S
Innate Immun; 2012 Jun; 18(3):518-30. PubMed ID: 21975728
[TBL] [Abstract][Full Text] [Related]
28. Target enzyme mutations are the molecular basis for resistance towards pharmacological inhibition of nicotinamide phosphoribosyltransferase.
Olesen UH; Petersen JG; Garten A; Kiess W; Yoshino J; Imai S; Christensen MK; Fristrup P; Thougaard AV; Björkling F; Jensen PB; Nielsen SJ; Sehested M
BMC Cancer; 2010 Dec; 10():677. PubMed ID: 21144000
[TBL] [Abstract][Full Text] [Related]
29. Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors as therapeutics: rationales, controversies, clinical experience.
Montecucco F; Cea M; Bauer I; Soncini D; Caffa I; Lasigliè D; Nahimana A; Uccelli A; Bruzzone S; Nencioni A
Curr Drug Targets; 2013 Jun; 14(6):637-43. PubMed ID: 23531116
[TBL] [Abstract][Full Text] [Related]
30. Synergy between the NAMPT inhibitor GMX1777(8) and pemetrexed in non-small cell lung cancer cells is mediated by PARP activation and enhanced NAD consumption.
Chan M; Gravel M; Bramoullé A; Bridon G; Avizonis D; Shore GC; Roulston A
Cancer Res; 2014 Nov; 74(21):5948-54. PubMed ID: 25145669
[TBL] [Abstract][Full Text] [Related]
31. Disparity in the induction of glutathione depletion, ROS formation, poly(ADP-ribose) polymerase-1 activation, and apoptosis by quinonoid derivatives of naphthalene in human cultured cells.
Lin CH; Huang CC; Wang TW; Wang YJ; Lin PH
Chem Biol Interact; 2007 Feb; 165(3):200-10. PubMed ID: 17224139
[TBL] [Abstract][Full Text] [Related]
32. Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer.
Pan JH; Zhou H; Zhu SB; Huang JL; Zhao XX; Ding H; Qin L; Pan YL
J Cell Physiol; 2019 Apr; 234(4):4385-4395. PubMed ID: 30191976
[TBL] [Abstract][Full Text] [Related]
33. Oxyresveratrol stimulates mucin production in an NAD
Hwang D; Jo H; Ma SH; Lim YH
Food Chem Toxicol; 2018 Aug; 118():880-888. PubMed ID: 29935245
[TBL] [Abstract][Full Text] [Related]
34. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
Zhang HS; Chen XY; Wu TC; Zhang FJ
J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
[TBL] [Abstract][Full Text] [Related]
35. Dependence of tumor cell lines and patient-derived tumors on the NAD salvage pathway renders them sensitive to NAMPT inhibition with GNE-618.
Xiao Y; Elkins K; Durieux JK; Lee L; Oeh J; Yang LX; Liang X; DelNagro C; Tremayne J; Kwong M; Liederer BM; Jackson PK; Belmont LD; Sampath D; O'Brien T
Neoplasia; 2013 Oct; 15(10):1151-60. PubMed ID: 24204194
[TBL] [Abstract][Full Text] [Related]
36. Antrodia camphorata extract (ACE)-induced apoptosis is associated with BMP4 expression and p53-dependent ROS generation in human colon cancer cells.
Ding R; Ning X; Ye M; Yin Y
J Ethnopharmacol; 2021 Mar; 268():113570. PubMed ID: 33181285
[TBL] [Abstract][Full Text] [Related]
37. p53-dependent glutamine usage determines susceptibility to oxidative stress in radioresistant head and neck cancer cells.
Chang HW; Lee M; Lee YS; Kim SH; Lee JC; Park JJ; Nam HY; Kim MR; Han MW; Kim SW; Kim SY
Cell Signal; 2021 Jan; 77():109820. PubMed ID: 33137455
[TBL] [Abstract][Full Text] [Related]
38. ROS and RNS induced apoptosis through p53 and iNOS mediated pathway by a dibasic hydroxamic acid molecule in leukemia cells.
Banerjee K; Ganguly A; Chakraborty P; Sarkar A; Singh S; Chatterjee M; Bhattacharya S; Choudhuri SK
Eur J Pharm Sci; 2014 Feb; 52():146-64. PubMed ID: 24269727
[TBL] [Abstract][Full Text] [Related]
39. Involvement of p53 in the cytotoxic activity of the NAMPT inhibitor FK866 in myeloid leukemic cells.
Thakur BK; Dittrich T; Chandra P; Becker A; Kuehnau W; Klusmann JH; Reinhardt D; Welte K
Int J Cancer; 2013 Feb; 132(4):766-74. PubMed ID: 22815158
[TBL] [Abstract][Full Text] [Related]
40. Targeting NAMPT for Therapeutic Intervention in Cancer and Inflammation: Structure-Based Drug Design and Biological Screening.
Pulla VK; Sriram DS; Soni V; Viswanadha S; Sriram D; Yogeeswari P
Chem Biol Drug Des; 2015 Oct; 86(4):881-94. PubMed ID: 25850461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
